CFM PHARMA HOLDING BV has a total of 16 patent applications. It increased the IP activity by 50.0%. Its first patent ever was published in 2012. It filed its patents most often in Australia, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and foods and drinks are MEDDAY PHARMACEUTICALS, NEW CHAPTER INC and ORTHO NUTRA LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Japan | 2 | |
#5 | United States | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 | |
#8 | Hungary | 1 | |
#9 | Mexico | 1 | |
#10 | Serbia | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special foods | |
#4 | Foods |
# | Name | Total Patents |
---|---|---|
#1 | Changoer Lekhram | 13 |
#2 | Meijerink Hendrik Jan Cornelis | 12 |
#3 | Lekhram Changoer | 3 |
#4 | Hendrik Jan Cornelis Meijerink | 3 |
#5 | De Kimpe Josephus Johannes | 2 |
#6 | Meijerink Hendrik Jan Cornells | 1 |
Publication | Filing date | Title |
---|---|---|
US2020246352A1 | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement | |
CN103561733A | Use of vanadium compounds for maintaining normaglycemia in a mammal |